Detalhe da pesquisa
1.
Holistic immunomodulation for small cell lung cancer.
Semin Cancer Biol
; 88: 96-105, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470543
2.
CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer.
Pharmacol Res
; 194: 106850, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37453674
3.
ß-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer.
Pharmacol Res
; 191: 106739, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948327
4.
[Chemical constituents from whole herb of Hedyotis scandens].
Zhongguo Zhong Yao Za Zhi
; 48(22): 6082-6087, 2023 Nov.
Artigo
em Chinês
| MEDLINE | ID: mdl-38114215
5.
Bacteria-based nanodrug for anticancer therapy.
Pharmacol Res
; 182: 106282, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35662630
6.
Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells.
Pharmacol Res
; 169: 105656, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33964470
7.
Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling.
Pharmacol Res
; 171: 105574, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34419228
8.
Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway.
Pharmacol Res
; 161: 105129, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783976
9.
Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer.
Int J Cancer
; 145(5): 1334-1345, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30786019
10.
[Research status and translational application of new extraction techniques of traditional Chinese medicine].
Zhongguo Zhong Yao Za Zhi
; 39(8): 1360-7, 2014 Apr.
Artigo
em Chinês
| MEDLINE | ID: mdl-25039165
11.
Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer.
Phytomedicine
; 128: 155431, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38537440
12.
PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy.
Cell Death Dis
; 13(11): 931, 2022 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344505
13.
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer.
Cancer Lett
; 515: 36-48, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34052328
14.
Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis.
J Exp Clin Cancer Res
; 39(1): 249, 2020 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208183
15.
Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non-Small Cell Lung Cancer.
Integr Cancer Ther
; 18: 1534735419890020, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838881